期刊文献+

胃复安治疗偏头痛疗效观察 被引量:1

Efficacy of metoclopramide in the treatment of migraine headache
下载PDF
导出
摘要 目的:观察胃复安(甲氧氯普胺)治疗急性偏头痛的疗效。方法:将63例急性偏头痛患者随机分为两组,观察组32例,采用甲氧氯普胺治疗,对照组31例,采用氟桂利嗪治疗,比较两组的疗效。结果:观察组有效26例,对照组有效23例,两组疗效比较差异无统计学意义(P>0.05)。结论:胃复安用于治疗急性偏头痛,安全有效。 Objective To observe the effects of metoclopramide in the treatment of acute migraine headache.Method The 63 cases of acute migraine headaches were randomly divided into two groups,the observation group(n = 32) was treated with metoclopramide,the control group(n = 31) using flunarizine,and the efficacy of the two groups was compared.Results The effective cases in the observation group was 26 cases,in the control group was 23 cases,the difference between the two groups was not significant(P 〉0.05) .Conclusion Metoclopramide treating acute migraine headaches is safe and effective.
作者 许冠思
出处 《吉林医学》 CAS 2010年第22期3684-3685,共2页 Jilin Medical Journal
关键词 胃复安 偏头痛 Metoclopramide Migraine headache
  • 相关文献

参考文献5

  • 1The International Headache Society.Headache classfication committee of the international headache society[J].Cephalalgia,1998,8(Suppl 7):19.
  • 2王波,罗巍.偏头痛遗传机制的研究进展[J].中华神经科杂志,2009,42(5):348-351. 被引量:7
  • 3宋文宣.实用内科药物治疗学[M].北京:人民卫生出版社,2002.369.
  • 4Raskin NH.Repetitive intravenous dihydroergotamine for treatment of intractable migraine[J].Neurology,1986,36(7):995.
  • 5Schwarberg MN.Application of metoclopramide specifity in migraine attacks therapy[J].Headache,1994,34(7):439.

二级参考文献25

  • 1Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia, 2004, 24 Suppl 1: 9-160.
  • 2Vanmolkot KR, Terwindt GM, Frants RR, et al. A gene for a new monogenic neurovascular migraine syndrome: a next step in unravelling molecular pathways for migraine? Cephalalgia, 2008, 28 : 471-473.
  • 3Pietrobon D. Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr Opin Neurobiol, 2005, 15: 257-265.
  • 4Imbrici P, Jaffe SL, Eunson LH, et al. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain, 2004, 127 Pt 12: 2682-2692.
  • 5Melliti K, Grabner M, Seabrook GR. The familial hemiplegic migraine mutation R192Q reduces G-protein-mediated inhibition of P/Q-type CaV2.1 calcium channels expressed in human embryonic kidney cells. J Physiol, 2003, 546: 337-347.
  • 6Weiss N, Sandoval A, Felix R, et al. The S218L familial hemiplegic migraine mutation promotes deinhibition of Cav2. 1 calcium channels during direct G-protein regulation. Pflugers Arch, 2008, 457: 315-326.
  • 7De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na ^+/K ^+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet, 2003, 33 : 192-196.
  • 8Stam AH, van den Maagdenberg AM, Haan J, et al. Genetics of migraine: an update with special attention to genetic comorbidity. Curr Opin Neural, 2008, 21: 288-293.
  • 9Ikeda K, Onaka T, Yamakado M, et al. Degeneration of the amygdala/piriform cortex and enhanced fear/anxiety behaviors in sodium pump alpha2 subunit (Atpla2)-deficient mice. J Neurosci, 2003, 23 : 4667-4676.
  • 10Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet, 2005, 366 : 371-377.

共引文献12

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部